Equazen eye q liquid
Natural health product licensed in Canada
- Other names
- Equazen eye q liquid citrus, Equazen eye q liquid vanilla
- Licence holder
- Soho Floridis UK Ltd.
- NPN or DIN-HM
- 80010512
- Status
- Inactive licence
- Licence date
- 29 May 2009
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Huile du corps de Sardine Potency : 186 mg EPA | 800 mg | Not calculated |
Non-medicinal ingredients
Huile de tournesol, Saveur de citron naturelle, Saveur de vanille naturelle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | Not specified | 3 Cuillère à thé | Not specified |
| Enfants | minimum: 2 years | 3 Cuillère à thé | Not specified |
| Adolescentes | Not specified | 3 Cuillère à thé | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support cognitive health and brain function as well as the development of the brain, eyes and nerves in children and adolescents. Improves concentration levels in children/adolescents with ADHD.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80010512
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.